{"id":"https://openalex.org/W2575139667","doi":"https://doi.org/10.1016/j.msard.2017.01.007","title":"Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypotheses","display_name":"Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypotheses","alternate_titles":[],"publication_year":2017,"publication_date":"2017-01-17","ids":{"openalex":"https://openalex.org/W2575139667","doi":"https://doi.org/10.1016/j.msard.2017.01.007","mag":"2575139667","pmid":"https://pubmed.ncbi.nlm.nih.gov/28283111"},"language":"en","primary_location":{"id":"doi:10.1016/j.msard.2017.01.007","doi":"https://doi.org/10.1016/j.msard.2017.01.007","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.msard.2017.01.007","pdf_url":null,"source":{"id":"https://openalex.org/S2764622253","display_name":"Multiple Sclerosis and Related Disorders","issn_l":"2211-0348","issn":["2211-0348","2211-0356"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple Sclerosis and Related Disorders","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2575139667"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://qmro.qmul.ac.uk/xmlui/handle/123456789/23518","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015754502","display_name":"Gavin Giovannoni","orcid":"https://orcid.org/0000-0001-9995-1700","observed_orcids":["https://orcid.org/0000-0001-9995-1700"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405263501","display_name":"Blizard Institute","ror":"https://ror.org/01y7pzx08","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405263501"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Gavin Giovannoni","raw_affiliation_strings":["Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK. Electronic address: g.giovannoni@qmul.ac.uk","Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK. Electronic address: g.giovannoni@qmul.ac.uk","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]},{"raw_affiliation_string":"Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036008316","display_name":"Gary Cutter","orcid":"https://orcid.org/0000-0002-8455-980X","observed_orcids":["https://orcid.org/0000-0002-8455-980X"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Gary Cutter","raw_affiliation_strings":["Department of Biostatistics, University of Alabama at Birmingham School of Public Health, Birmingham, AL, USA. Electronic address: cutterg@uab.edu","Department of Biostatistics, University of Alabama at Birmingham School of Public Health, Birmingham, AL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, University of Alabama at Birmingham School of Public Health, Birmingham, AL, USA. Electronic address: cutterg@uab.edu","institution_ids":["https://openalex.org/I32389192"]},{"raw_affiliation_string":"Department of Biostatistics, University of Alabama at Birmingham School of Public Health, Birmingham, AL, USA","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061993323","display_name":"Maria Pia Sormani","orcid":"https://orcid.org/0000-0001-6892-104X","observed_orcids":["https://orcid.org/0000-0001-6892-104X"]},"institutions":[{"id":"https://openalex.org/I83816512","display_name":"University of Genoa","ror":"https://ror.org/0107c5v14","country_code":"IT","type":"education","lineage":["https://openalex.org/I83816512"]}],"countries":["IT"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Maria Pia Sormani","raw_affiliation_strings":["Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy. Electronic address: mariapia.sormani@unige.it","Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy. Electronic address: mariapia.sormani@unige.it","institution_ids":["https://openalex.org/I83816512"]},{"raw_affiliation_string":"Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy","institution_ids":["https://openalex.org/I83816512"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035104330","display_name":"Shibeshih Mitiku Belachew","orcid":"https://orcid.org/0000-0003-3976-1950","observed_orcids":["https://orcid.org/0000-0003-3976-1950"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Shibeshih Belachew","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd, Basel, Switzerland. Electronic address: shibeshih.belachew@roche.com","F. Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd, Basel, Switzerland. Electronic address: shibeshih.belachew@roche.com","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066502187","display_name":"Robert Hyde","orcid":"https://orcid.org/0000-0002-8705-9405","observed_orcids":["https://orcid.org/0000-0002-8705-9405"]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Robert Hyde","raw_affiliation_strings":["Biogen, Cambridge, MA, USA. Electronic address: robert.hyde@biogen.com","Biogen, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biogen, Cambridge, MA, USA. Electronic address: robert.hyde@biogen.com","institution_ids":["https://openalex.org/I1297540436"]},{"raw_affiliation_string":"Biogen, Cambridge, MA, USA","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071219650","display_name":"Harold Koendgen","orcid":"https://orcid.org/0000-0002-8496-4952","observed_orcids":["https://orcid.org/0000-0002-8496-4952"]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Harold Koendgen","raw_affiliation_strings":["Biogen, Cambridge, MA, USA. Electronic address: harold.koendgen@gmail.com","Biogen, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biogen, Cambridge, MA, USA. Electronic address: harold.koendgen@gmail.com","institution_ids":["https://openalex.org/I1297540436"]},{"raw_affiliation_string":"Biogen, Cambridge, MA, USA","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060947854","display_name":"Volker A. Knappertz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109720","display_name":"Teva Pharmaceuticals (Israel)","ror":"https://ror.org/01wfv3m53","country_code":"IL","type":"company","lineage":["https://openalex.org/I4210109720"]}],"countries":["IL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Volker Knappertz","raw_affiliation_strings":["Teva Pharmaceuticals, Netanya, Israel. Electronic address: Volker.Knappertz@tevapharm.com","Teva Pharmaceuticals, Netanya, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Pharmaceuticals, Netanya, Israel. Electronic address: Volker.Knappertz@tevapharm.com","institution_ids":["https://openalex.org/I4210109720"]},{"raw_affiliation_string":"Teva Pharmaceuticals, Netanya, Israel","institution_ids":["https://openalex.org/I4210109720"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050196672","display_name":"Davorka Tomic","orcid":"https://orcid.org/0000-0002-1484-1850","observed_orcids":["https://orcid.org/0000-0002-1484-1850"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Davorka Tomic","raw_affiliation_strings":["Novartis Pharma AG, Basel, Switzerland. Electronic address: davorka.tomic@novartis.com","Novartis Pharma AG, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Basel, Switzerland. Electronic address: davorka.tomic@novartis.com","institution_ids":["https://openalex.org/I1283582996"]},{"raw_affiliation_string":"Novartis Pharma AG, Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076575343","display_name":"David Leppert","orcid":"https://orcid.org/0000-0001-6172-801X","observed_orcids":["https://orcid.org/0000-0001-6172-801X"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"David Leppert","raw_affiliation_strings":["Novartis Pharma AG, Basel, Switzerland. Electronic address: david.leppert@novartis.com","Novartis Pharma AG, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Basel, Switzerland. Electronic address: david.leppert@novartis.com","institution_ids":["https://openalex.org/I1283582996"]},{"raw_affiliation_string":"Novartis Pharma AG, Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111667085","display_name":"Robert M. Herndon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I29606459","display_name":"University of Mississippi Medical Center","ror":"https://ror.org/044pcn091","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I29606459","https://openalex.org/I4210141039"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Robert Herndon","raw_affiliation_strings":["University of Mississippi Medical Center, Jackson, MS, USA. Electronic address: rherndon@umc.edu","University of Mississippi Medical Center, Jackson, MS, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Mississippi Medical Center, Jackson, MS, USA. Electronic address: rherndon@umc.edu","institution_ids":["https://openalex.org/I29606459"]},{"raw_affiliation_string":"University of Mississippi Medical Center, Jackson, MS, USA","institution_ids":["https://openalex.org/I29606459"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037442059","display_name":"Claudia A. M. Gandini Wheeler\u2010Kingshott","orcid":"https://orcid.org/0000-0002-4832-1300","observed_orcids":["https://orcid.org/0000-0002-4832-1300"]},"institutions":[{"id":"https://openalex.org/I4210151618","display_name":"National Hospital for Neurology and Neurosurgery","ror":"https://ror.org/048b34d51","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1340918713","https://openalex.org/I4210151618"]},{"id":"https://openalex.org/I4405260083","display_name":"UCL Queen Square Institute of Neurology","ror":"https://ror.org/0370htr03","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I4405260083","https://openalex.org/I45129253"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Claudia A.M. Wheeler-Kingshott","raw_affiliation_strings":["NMR Research Unit, Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, Queen Square, London, UK. Electronic address: c.wheeler-kingshott@ucl.ac.uk","NMR Research Unit, Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, Queen Square, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NMR Research Unit, Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, Queen Square, London, UK. Electronic address: c.wheeler-kingshott@ucl.ac.uk","institution_ids":["https://openalex.org/I4210151618","https://openalex.org/I4405260083","https://openalex.org/I45129253"]},{"raw_affiliation_string":"NMR Research Unit, Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, Queen Square, London, UK","institution_ids":["https://openalex.org/I4210151618","https://openalex.org/I4405260083","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067383775","display_name":"Olga Ciccarelli","orcid":"https://orcid.org/0000-0001-7485-1367","observed_orcids":["https://orcid.org/0000-0001-7485-1367"]},"institutions":[{"id":"https://openalex.org/I4210138523","display_name":"UCL Biomedical Research Centre","ror":"https://ror.org/03r9qc142","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I124357947","https://openalex.org/I1340918713","https://openalex.org/I34931013","https://openalex.org/I4210138523","https://openalex.org/I45129253"]},{"id":"https://openalex.org/I4210151618","display_name":"National Hospital for Neurology and Neurosurgery","ror":"https://ror.org/048b34d51","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1340918713","https://openalex.org/I4210151618"]},{"id":"https://openalex.org/I4405260083","display_name":"UCL Queen Square Institute of Neurology","ror":"https://ror.org/0370htr03","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I4405260083","https://openalex.org/I45129253"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Olga Ciccarelli","raw_affiliation_strings":["NMR Research Unit, Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, Queen Square, London, UK; NIHR University College Hospitals Biomedical Research Centre (BRC), UK. Electronic address: o.ciccarelli@ucl.ac.uk","NIHR University College Hospitals Biomedical Research Centre (BRC), UK","NMR Research Unit, Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, Queen Square, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NMR Research Unit, Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, Queen Square, London, UK; NIHR University College Hospitals Biomedical Research Centre (BRC), UK. Electronic address: o.ciccarelli@ucl.ac.uk","institution_ids":["https://openalex.org/I4210138523","https://openalex.org/I4210151618","https://openalex.org/I4405260083","https://openalex.org/I45129253"]},{"raw_affiliation_string":"NIHR University College Hospitals Biomedical Research Centre (BRC), UK","institution_ids":[]},{"raw_affiliation_string":"NMR Research Unit, Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, Queen Square, London, UK","institution_ids":["https://openalex.org/I4210151618","https://openalex.org/I4405260083","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026824813","display_name":"David L. Selwood","orcid":"https://orcid.org/0000-0002-6817-5064","observed_orcids":["https://orcid.org/0000-0002-6817-5064"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"David Selwood","raw_affiliation_strings":["Wolfson Institute for Biomedical Research, UCL, London, UK. Electronic address: d.selwood@ucl.ac.uk","Wolfson Institute for Biomedical Research, UCL, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wolfson Institute for Biomedical Research, UCL, London, UK. Electronic address: d.selwood@ucl.ac.uk","institution_ids":["https://openalex.org/I45129253"]},{"raw_affiliation_string":"Wolfson Institute for Biomedical Research, UCL, London, UK","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011068908","display_name":"Elisabetta Verdun di Cantogno","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113211","display_name":"Merck Serono S.A. (Switzerland)","ror":"https://ror.org/01vp49361","country_code":"CH","type":"company","lineage":["https://openalex.org/I164928964","https://openalex.org/I4210113211"]}],"countries":["CH"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Elisabetta Verdun di Cantogno","raw_affiliation_strings":["Merck, Aubonne, Switzerland. Electronic address: elisabetta.verdun-di-cantogno@merckgroup.com","Merck, Aubonne, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck, Aubonne, Switzerland. Electronic address: elisabetta.verdun-di-cantogno@merckgroup.com","institution_ids":["https://openalex.org/I4210113211"]},{"raw_affiliation_string":"Merck, Aubonne, Switzerland","institution_ids":["https://openalex.org/I4210113211"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005481141","display_name":"Ali-Fr\u00e9d\u00e9ric Ben-Amor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113211","display_name":"Merck Serono S.A. (Switzerland)","ror":"https://ror.org/01vp49361","country_code":"CH","type":"company","lineage":["https://openalex.org/I164928964","https://openalex.org/I4210113211"]}],"countries":["CH"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Ali-Frederic Ben-Amor","raw_affiliation_strings":["Merck, Aubonne, Switzerland. Electronic address: ali-frederic.ben-amor@merckgroup.com","Merck, Aubonne, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck, Aubonne, Switzerland. Electronic address: ali-frederic.ben-amor@merckgroup.com","institution_ids":["https://openalex.org/I4210113211"]},{"raw_affiliation_string":"Merck, Aubonne, Switzerland","institution_ids":["https://openalex.org/I4210113211"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5128195827","display_name":"Paul McMahan Matthews","orcid":"https://orcid.org/0000-0002-1619-8328","observed_orcids":["https://orcid.org/0000-0002-1619-8328"]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Paul Matthews","raw_affiliation_strings":["Department of Medicine, Imperial College, London, UK. Electronic address: p.matthews@imperial.ac.uk","Department of Medicine, Imperial College, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Imperial College, London, UK. Electronic address: p.matthews@imperial.ac.uk","institution_ids":["https://openalex.org/I47508984"]},{"raw_affiliation_string":"Department of Medicine, Imperial College, London, UK","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009538524","display_name":"Daniele Carassiti","orcid":"https://orcid.org/0000-0002-1664-4324","observed_orcids":["https://orcid.org/0000-0002-1664-4324"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405263501","display_name":"Blizard Institute","ror":"https://ror.org/01y7pzx08","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405263501"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Daniele Carassiti","raw_affiliation_strings":["Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK. Electronic address: d.carassiti@qmul.ac.uk","Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK. Electronic address: d.carassiti@qmul.ac.uk","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]},{"raw_affiliation_string":"Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016912802","display_name":"David Baker","orcid":"https://orcid.org/0000-0002-8872-8711","observed_orcids":["https://orcid.org/0000-0002-8872-8711"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405263501","display_name":"Blizard Institute","ror":"https://ror.org/01y7pzx08","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405263501"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"David Baker","raw_affiliation_strings":["Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK. Electronic address: david.baker@qmul.ac.uk","Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK. Electronic address: david.baker@qmul.ac.uk","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]},{"raw_affiliation_string":"Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5057445606","display_name":"Klaus Schmierer","orcid":"https://orcid.org/0000-0002-9293-8893","observed_orcids":["https://orcid.org/0000-0002-9293-8893"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405263501","display_name":"Blizard Institute","ror":"https://ror.org/01y7pzx08","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405263501"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Klaus Schmierer","raw_affiliation_strings":["Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK. Electronic address: k.schmierer@qmul.ac.uk","Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK. Electronic address: k.schmierer@qmul.ac.uk","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]},{"raw_affiliation_string":"Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":15,"corresponding_author_ids":["https://openalex.org/A5005481141","https://openalex.org/A5009538524","https://openalex.org/A5011068908","https://openalex.org/A5015754502","https://openalex.org/A5016912802","https://openalex.org/A5026824813","https://openalex.org/A5035104330","https://openalex.org/A5036008316","https://openalex.org/A5037442059","https://openalex.org/A5050196672","https://openalex.org/A5057445606","https://openalex.org/A5060947854","https://openalex.org/A5061993323","https://openalex.org/A5066502187","https://openalex.org/A5067383775","https://openalex.org/A5071219650","https://openalex.org/A5076575343","https://openalex.org/A5111667085","https://openalex.org/A5128195827"],"corresponding_institution_ids":["https://openalex.org/I118019719","https://openalex.org/I1283582996","https://openalex.org/I1297540436","https://openalex.org/I166337079","https://openalex.org/I29606459","https://openalex.org/I32389192","https://openalex.org/I4210109720","https://openalex.org/I4210113211","https://openalex.org/I4210138523","https://openalex.org/I4210151618","https://openalex.org/I4405260083","https://openalex.org/I4405263501","https://openalex.org/I45129253","https://openalex.org/I47508984","https://openalex.org/I83816512"],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":null,"fwci":2.111,"has_fulltext":false,"cited_by_count":124,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.90198675,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"12","issue":null,"first_page":"70","last_page":"78"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11735","display_name":"Peripheral Neuropathies and Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11827","display_name":"Polyomavirus and related diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.925000011920929},{"id":"https://openalex.org/keywords/progressive-multiple-sclerosis","display_name":"progressive multiple sclerosis","score":0.8199999928474426},{"id":"https://openalex.org/keywords/neuroaxonal-degeneration","display_name":"neuroaxonal degeneration","score":0.8289999961853027},{"id":"https://openalex.org/keywords/anti-inflammatory-therapy","display_name":"anti-inflammatory therapy","score":0.6399999856948853},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.7400000095367432},{"id":"https://openalex.org/keywords/trial-design","display_name":"trial design","score":0.628000020980835},{"id":"https://openalex.org/keywords/neurodegeneration","display_name":"neurodegeneration","score":0.7379999756813049},{"id":"https://openalex.org/keywords/siponimod","display_name":"siponimod","score":0.7429999709129333},{"id":"https://openalex.org/keywords/anti-cd20-therapy","display_name":"anti-CD20 therapy","score":0.9139999747276306},{"id":"https://openalex.org/keywords/primary-progressive-multiple-sclerosis","display_name":"primary progressive multiple sclerosis","score":0.6859999895095825},{"id":"https://openalex.org/keywords/secondary-progressive-multiple-sclerosis","display_name":"secondary progressive multiple sclerosis","score":0.9929999709129333}],"concepts":[{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.827017068862915},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7807803750038147},{"id":"https://openalex.org/C2778843634","wikidata":"https://www.wikidata.org/wiki/Q2013780","display_name":"Ocrelizumab","level":4,"score":0.6695209741592407},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5379832983016968},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.4940955936908722},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.4632917642593384},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4332837462425232},{"id":"https://openalex.org/C2780596555","wikidata":"https://www.wikidata.org/wiki/Q206901","display_name":"Amyotrophic lateral sclerosis","level":3,"score":0.4155796766281128},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.22151824831962585},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.21984562277793884},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.11873430013656616},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.10184270143508911},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001369","descriptor_name":"Axons","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020528","descriptor_name":"Multiple Sclerosis, Chronic Progressive","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D020528","descriptor_name":"Multiple Sclerosis, Chronic Progressive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D020528","descriptor_name":"Multiple Sclerosis, Chronic Progressive","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1016/j.msard.2017.01.007","doi":"https://doi.org/10.1016/j.msard.2017.01.007","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.msard.2017.01.007","pdf_url":null,"source":{"id":"https://openalex.org/S2764622253","display_name":"Multiple Sclerosis and Related Disorders","issn_l":"2211-0348","issn":["2211-0348","2211-0356"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple Sclerosis and Related Disorders","raw_type":"journal-article"},{"id":"pmid:28283111","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28283111","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple sclerosis and related disorders","raw_type":"Journal Article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:1538768","doi":null,"is_oa":false,"landing_page_url":"https://discovery.ucl.ac.uk/id/eprint/1538768/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Multiple Sclerosis and Related Disorders , 12 pp. 70-78. (2017)","raw_type":"Article"},{"id":"pmh:oai:iris.unige.it:11567/898301","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11567/898301","pdf_url":null,"source":{"id":"https://openalex.org/S4377196291","display_name":"CINECA IRIS Institutial Research Information System (University of Genoa)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I83816512","host_organization_name":"University of Genoa","host_organization_lineage":["https://openalex.org/I83816512"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:qmro.qmul.ac.uk:123456789/23518","doi":null,"is_oa":true,"landing_page_url":"http://qmro.qmul.ac.uk/xmlui/handle/123456789/23518","pdf_url":null,"source":{"id":"https://openalex.org/S4306400530","display_name":"Queen Mary Research Online (Queen Mary University of London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I166337079","host_organization_name":"Queen Mary University of London","host_organization_lineage":["https://openalex.org/I166337079"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":{"id":"pmh:oai:qmro.qmul.ac.uk:123456789/23518","doi":null,"is_oa":true,"landing_page_url":"http://qmro.qmul.ac.uk/xmlui/handle/123456789/23518","pdf_url":null,"source":{"id":"https://openalex.org/S4306400530","display_name":"Queen Mary Research Online (Queen Mary University of London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I166337079","host_organization_name":"Queen Mary University of London","host_organization_lineage":["https://openalex.org/I166337079"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4250834592","display_name":"Capital award for UK DRI at Imperial College London","funder_award_id":"MC_PC_17114","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"},{"id":"https://openalex.org/G4618879636","display_name":"Biomedical Catalyst \u2013 Drug product production, clinical support studies, and phase 1 trial of a new MS drug","funder_award_id":"MC_PC_13037","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"},{"id":"https://openalex.org/G5721502827","display_name":"NIHR Senior Investigator Award","funder_award_id":"NF-SI-0514-10022","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"},{"id":"https://openalex.org/G5959522739","display_name":"Axon and myelin damage assessed using advanced diffusion imaging: from mathematical models to clinical applications","funder_award_id":"EP/I027084/1","funder_id":"https://openalex.org/F4320334627","funder_display_name":"Engineering and Physical Sciences Research Council"},{"id":"https://openalex.org/G8195503501","display_name":"Consortium Building","funder_award_id":"MR/K501013/1","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"}],"funders":[{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"},{"id":"https://openalex.org/F4320334627","display_name":"Engineering and Physical Sciences Research Council","ror":"https://ror.org/0439y7842"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":58,"referenced_works":["https://openalex.org/W83202250","https://openalex.org/W83427670","https://openalex.org/W153101962","https://openalex.org/W591061738","https://openalex.org/W1927288687","https://openalex.org/W1967990636","https://openalex.org/W1969185231","https://openalex.org/W1969747017","https://openalex.org/W1975104912","https://openalex.org/W1975254445","https://openalex.org/W1979592318","https://openalex.org/W1982614515","https://openalex.org/W2012102744","https://openalex.org/W2017187699","https://openalex.org/W2020194517","https://openalex.org/W2032464570","https://openalex.org/W2037636284","https://openalex.org/W2046226207","https://openalex.org/W2047413783","https://openalex.org/W2048324178","https://openalex.org/W2051274614","https://openalex.org/W2056736742","https://openalex.org/W2065189003","https://openalex.org/W2074708251","https://openalex.org/W2095116045","https://openalex.org/W2095170181","https://openalex.org/W2103758700","https://openalex.org/W2104613203","https://openalex.org/W2105206040","https://openalex.org/W2107008240","https://openalex.org/W2117485026","https://openalex.org/W2119961485","https://openalex.org/W2122542523","https://openalex.org/W2127572783","https://openalex.org/W2128774978","https://openalex.org/W2131772954","https://openalex.org/W2144969187","https://openalex.org/W2145185401","https://openalex.org/W2146853725","https://openalex.org/W2150582104","https://openalex.org/W2151576334","https://openalex.org/W2152132921","https://openalex.org/W2157401887","https://openalex.org/W2158515030","https://openalex.org/W2160413407","https://openalex.org/W2162978315","https://openalex.org/W2164581953","https://openalex.org/W2167365151","https://openalex.org/W2168376219","https://openalex.org/W2168930516","https://openalex.org/W2169370050","https://openalex.org/W2244455943","https://openalex.org/W2267348707","https://openalex.org/W2325038063","https://openalex.org/W2332064267","https://openalex.org/W2350240851","https://openalex.org/W2777494229","https://openalex.org/W4242535183"],"related_works":["https://openalex.org/W171934754","https://openalex.org/W2065200510","https://openalex.org/W2022517665","https://openalex.org/W2150752323","https://openalex.org/W170441319","https://openalex.org/W2967983128","https://openalex.org/W2189098834","https://openalex.org/W1970759054","https://openalex.org/W2489308363","https://openalex.org/W3121510678"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2575139667","counts_by_year":[{"year":2026,"cited_by_count":13},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":16},{"year":2021,"cited_by_count":13},{"year":2020,"cited_by_count":13},{"year":2019,"cited_by_count":19},{"year":2018,"cited_by_count":18},{"year":2017,"cited_by_count":8}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2017-01-26T00:00:00"}
